Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

228 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Fibrosis and angiogenesis.
Kalluri R, Sukhatme VP. Kalluri R, et al. Among authors: sukhatme vp. Curr Opin Nephrol Hypertens. 2000 Jul;9(4):413-8. doi: 10.1097/00041552-200007000-00013. Curr Opin Nephrol Hypertens. 2000. PMID: 10926178 Review.
Soluble endoglin contributes to the pathogenesis of preeclampsia.
Venkatesha S, Toporsian M, Lam C, Hanai J, Mammoto T, Kim YM, Bdolah Y, Lim KH, Yuan HT, Libermann TA, Stillman IE, Roberts D, D'Amore PA, Epstein FH, Sellke FW, Romero R, Sukhatme VP, Letarte M, Karumanchi SA. Venkatesha S, et al. Among authors: sukhatme vp. Nat Med. 2006 Jun;12(6):642-9. doi: 10.1038/nm1429. Epub 2006 Jun 4. Nat Med. 2006. PMID: 16751767
Preeclampsia and future cardiovascular disease: potential role of altered angiogenesis and insulin resistance.
Wolf M, Hubel CA, Lam C, Sampson M, Ecker JL, Ness RB, Rajakumar A, Daftary A, Shakir AS, Seely EW, Roberts JM, Sukhatme VP, Karumanchi SA, Thadhani R. Wolf M, et al. Among authors: sukhatme vp. J Clin Endocrinol Metab. 2004 Dec;89(12):6239-43. doi: 10.1210/jc.2004-0548. J Clin Endocrinol Metab. 2004. PMID: 15579783
Angiogenic imbalance in the pathophysiology of preeclampsia: newer insights.
Bdolah Y, Sukhatme VP, Karumanchi SA. Bdolah Y, et al. Among authors: sukhatme vp. Semin Nephrol. 2004 Nov;24(6):548-56. doi: 10.1016/s0270-9295(04)00125-1. Semin Nephrol. 2004. PMID: 15529289 Review.
Insulin resistance and alterations in angiogenesis: additive insults that may lead to preeclampsia.
Thadhani R, Ecker JL, Mutter WP, Wolf M, Smirnakis KV, Sukhatme VP, Levine RJ, Karumanchi SA. Thadhani R, et al. Among authors: sukhatme vp. Hypertension. 2004 May;43(5):988-92. doi: 10.1161/01.HYP.0000124460.67539.1d. Epub 2004 Mar 15. Hypertension. 2004. PMID: 15023932
Activation of the orphan endothelial receptor Tie1 modifies Tie2-mediated intracellular signaling and cell survival.
Yuan HT, Venkatesha S, Chan B, Deutsch U, Mammoto T, Sukhatme VP, Woolf AS, Karumanchi SA. Yuan HT, et al. Among authors: sukhatme vp. FASEB J. 2007 Oct;21(12):3171-83. doi: 10.1096/fj.07-8487com. Epub 2007 May 15. FASEB J. 2007. PMID: 17504972
Angiopoietin 2 is a potential mediator of high-dose interleukin 2-induced vascular leak.
Gallagher DC, Bhatt RS, Parikh SM, Patel P, Seery V, McDermott DF, Atkins MB, Sukhatme VP. Gallagher DC, et al. Among authors: sukhatme vp. Clin Cancer Res. 2007 Apr 1;13(7):2115-20. doi: 10.1158/1078-0432.CCR-06-2509. Clin Cancer Res. 2007. PMID: 17404094
Lipocalin 2 antagonizes the proangiogenic action of ras in transformed cells.
Venkatesha S, Hanai J, Seth P, Karumanchi SA, Sukhatme VP. Venkatesha S, et al. Among authors: sukhatme vp. Mol Cancer Res. 2006 Nov;4(11):821-9. doi: 10.1158/1541-7786.MCR-06-0110. Mol Cancer Res. 2006. PMID: 17114340
Microarray analysis of in vitro pericyte differentiation reveals an angiogenic program of gene expression.
Kale S, Hanai J, Chan B, Karihaloo A, Grotendorst G, Cantley L, Sukhatme VP. Kale S, et al. Among authors: sukhatme vp. FASEB J. 2005 Feb;19(2):270-1. doi: 10.1096/fj.04-1604fje. Epub 2004 Dec 3. FASEB J. 2005. PMID: 15579670
Antiangiogenic property of human thrombin.
Chan B, Merchan JR, Kale S, Sukhatme VP. Chan B, et al. Among authors: sukhatme vp. Microvasc Res. 2003 Jul;66(1):1-14. doi: 10.1016/s0026-2862(03)00037-2. Microvasc Res. 2003. PMID: 12826069 Review.
228 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page